Patents by Inventor Vikas Chandra Dev

Vikas Chandra Dev has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220002283
    Abstract: Co-crystals of meloxicam co-formers can be prepared by co-crystallization from a polar solvent, such as aqueous dimethyl sulfoxide; or by slurry processes, such as with ethyl acetate. Such co-crystals have improved purities and are physically stable under storage for several months.
    Type: Application
    Filed: November 4, 2019
    Publication date: January 6, 2022
    Applicant: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao JETTI, Srinivas ENUGULA, Subramanyam DANDALA, Sureshbabu JAYACHANDRA, Vijaya Krishna RAVI, Venkata Naga Vikas Chandra Dev RAVI
  • Patent number: 10738071
    Abstract: The present disclosure provides novel crystalline sofosbuvir form-M3 and a process for the preparation of sofosbuvir form-M3. The crystalline sofosbuvir form-M3 disclosed herein may be useful in the formulation of pharmaceutical dosage forms.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: August 11, 2020
    Assignee: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, Anjaneyaraju Indukuri, Narasimha Murty Pilli, Ravi Venkata Naga Vikas Chandra Dev, Vijaya Krishna Ravi
  • Patent number: 10344009
    Abstract: A process for the preparation of intermediates 9, useful in the synthesis of sofosbuvir, as well as intermediates of formula [12] are disclosed herein.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: July 9, 2019
    Assignee: Mylan Laboratories Limited
    Inventors: Sureshbabu Jayachandra, Vipin Kumar Kaushik, Vijaya Krishna Ravi, Vikas Chandra Dev, Saiprasad Kottolla, Potla Venkata Srinivasa Rao, Srinivas Vakiti, Chaitanya Muggu, Subramanyam Dandala
  • Publication number: 20190100550
    Abstract: The present disclosure provides novel crystalline sofosbuvir form-M3 and a process for the preparation of sofosbuvir form-M3. The crystalline sofosbuvir form-M3 disclosed herein may be useful in the formulation of pharmaceutical dosage forms.
    Type: Application
    Filed: March 17, 2017
    Publication date: April 4, 2019
    Applicant: Mylan Laboratories Limited
    Inventors: Ramakoteswara Rao Jetti, Hemant Malhari Mande, Anjaneyaraju Indukuri, Narasimha Murty Pilli, Ravi Venkata Haga Vikas Chandra Dev, Vijaya Krishna Ravi
  • Publication number: 20180312484
    Abstract: A process for the preparation of intermediates 9, useful in the synthesis of sofosbuvir, as well as intermediates of formula [12] are disclosed herein.
    Type: Application
    Filed: November 3, 2016
    Publication date: November 1, 2018
    Applicant: Mylan Laboratories Limited
    Inventors: Sureshbabu Jayachandra, Vipin Kumar Kaushik, Vijaya Krishna RAVI, Vikas Chandra Dev, Saiprasad Kottolla, Potla Venkata Srinivasa Rao, Srinivas Vakiti, Chaitanya Muggu, Subramanyam Dandala